CRISPR Therapeutics AG (CRSP)

CIK 1674416 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CRISPR Therapeutics AG.

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0000940594-26-000049
Aug 11, 202640001193125-26-345111
Aug 3, 20268-K0001193125-26-330644
Aug 3, 202610-Q0001193125-26-330672
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002146
Jun 9, 202640001193125-26-264286
Jun 9, 202640001193125-26-264290
Jun 9, 202640001193125-26-264279
Jun 9, 202640001193125-26-264390
Jun 9, 202640001193125-26-264288
Jun 9, 202640001193125-26-264287
Jun 9, 202640001193125-26-264282
Jun 9, 202640001193125-26-264289
Jun 9, 202640001193125-26-264285
Jun 9, 202640001193125-26-264382
Jun 5, 2026S-80001193125-26-258473
Jun 4, 20268-K0001193125-26-257593
Jun 2, 202640001193125-26-253929
Jun 2, 202640001193125-26-253926
Jun 2, 202640001193125-26-253925
Jun 1, 202640001193125-26-251817
May 15, 2026SCHEDULE 13G/A0000940594-26-000027
May 14, 2026SCHEDULE 13G0001422849-26-000051
May 4, 20268-K0001193125-26-204147
May 4, 202610-Q0001193125-26-204188